ABBOTT LABORATORIES A/S: Financial statements 2014
CVR: 31528615
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
ABBOTT LABORATORIES A/S (CVR 31528615) has filed annual accounts for 2014. In 2014, the company reported revenue of DKK 149,805,234 and a net result of DKK 15,091,152 compared with DKK 3,211,458 the year before. That is a decrease of 13.5% compared with the year before. The profit margin was 10.1%. Equity in the 2014 report amounted to DKK 39,381,370. The solvency ratio was 62.8%.
- Revenue
- DKK 149,805,234
- Gross Profit
- DKK 51,260,164
- Profit/Loss
- DKK 15,091,152
- Equity
- DKK 39,381,370
- Total Assets
- DKK 62,669,587
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | 149.8 mio. | 51.3 mio. | 15.1 mio. | 39.4 mio. | - |
| 2013 | 173.2 mio. | 39.9 mio. | 3.2 mio. | 24.3 mio. | 41 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
As of September 9, 2014, EY Godkendt Revisionspartnerselskab has been appointed auditor of ABBOTT LABORATORIES A/S.
As of September 9, 2014, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of ABBOTT LABORATORIES A/S.
ABBOTT LABORATORIES A/S has published its annual report for 2013. Revenue came to DKK 173,165,784, and the net result was DKK 3,211,458.
About ABBOTT LABORATORIES A/S
ABBOTT LABORATORIES A/S is a Danish company of the type Aktieselskab based in København S, founded in 1971. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Karl Andreas Almroth. The board consists of Bradley Jay Slater (chair), Fredrik Björn Anders Björnulfson and Karl Andreas Almroth. The company is owned by ABBOTT MEDICAL OVERSEAS CYPRUS LIMITED. The company has 48 employees (2026). In 2025, the company reported revenue of DKK 412,831,732 and a net result of DKK 63,142,932 compared with DKK 8,276,415 the year before. Equity in the 2025 report amounted to DKK 74,374,860.